9780762300648-0762300647-Advances in Medicinal Chemistry (Volume 4)

Advances in Medicinal Chemistry (Volume 4)

ISBN-13: 9780762300648
ISBN-10: 0762300647
Edition: 1
Author: B.E. Maryanoff, A.B. Reitz
Publication date: 1999
Publisher: Elsevier Science
Format: Hardcover 321 pages
FREE US shipping

Book details

ISBN-13: 9780762300648
ISBN-10: 0762300647
Edition: 1
Author: B.E. Maryanoff, A.B. Reitz
Publication date: 1999
Publisher: Elsevier Science
Format: Hardcover 321 pages

Summary

Advances in Medicinal Chemistry (Volume 4) (ISBN-13: 9780762300648 and ISBN-10: 0762300647), written by authors B.E. Maryanoff, A.B. Reitz, was published by Elsevier Science in 1999. With an overall rating of 3.9 stars, it's a notable title among other Molecular Biology (Evolution, Organic, Chemistry, General & Reference, Chemistry, Pharmacology, Pharmacy, Biology, Biological Sciences) books. You can easily purchase or rent Advances in Medicinal Chemistry (Volume 4) (Hardcover) from BooksRun, along with many other new and used Molecular Biology books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.3.

Description

Volume 4 of Advances in Medicinal Chemistry is comprised of six chapters on a wide range of topics in medicinal chemistry, including molecular modeling, structure-based drug design, organic synthesis, peptide conformational analysis, biological assessment, structure-activity correlation, and lead optimization. Chapter 1 presents an account about amino acid-based peptide mimetics corresponding to b-turn, loop, helical motifs in proteins as a probe of ligand-receptor and ligand-enzyme molecular interactions. Chapter 2 addresses new facets of the medicinal chemistry of the important anticancer drug Taxol® (paclitaxel). Chapter 3 relates an account of the search for new drugs for the treatment of malaria based on the natural product artemisinin. Chapter 4 applies computational chemistry to the evaluation of compound libraries for biological testing. Chapter 5 describes the construction of a 3-dimensional molecular model of the human thrombin receptor, the first protease-activated G-protein coupled receptor (PAR-1), as a means to explore the intermolecular contacts involved in agonist peptide recognition. Finally, Chapter 6 describes the research conducted at Merck on inhibitors of farnesyl transferase as a potential treatment for human cancers.
Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book